Surface silver-doping of biocompatible glass to induce antibacterial properties. Part I: Massive glass.

E Verné, M Miola, C Vitale Brovarone, M Cannas, S Gatti, G Fucale, G Maina, A Massé, S Di Nunzio
Author Information
  1. E Verné: Materials Science and Chemical Engineering Department, Polytechnic of Turin, Turin, Italy. enrica.verne@polito.it

Abstract

A glass belonging to the system SiO(2)-Al(2)O(3)-CaO-Na(2)O has been subjected to a patented ion-exchange treatment to induce surface antibacterial activity by doping with silver ions. Doped samples have been characterized by means of X-Ray diffraction (XRD), scanning electron microscopy (SEM) observation, energy dispersion spectrometry (EDS) analysis, in vitro bioactivity test, Ag(+) leaching test by graphite furnace atomic absorption spectroscopy (GFAAS) analyses, cytotoxicity tests by fibroblasts adhesion and proliferation, adsorption of IgA and IgG on to the material to evaluate its inflammatory property and antibacterial tests (cultures with Staphylococcus aureus and Escherichia coli). In vitro tests results demonstrated that the modified glass maintains the same biocompatibility of the untreated one and, moreover, it acquires an antimicrobial action against tested bacteria. This method can be selected to realize glass or glass-ceramic bone substitutes as well as coatings on bio-inert devices, providing safety against bacterial colonization thus reducing the risks of infections nearby the implant site. The present work is the carrying on of a previous research activity, concerning the application of an ion-exchange treatment on glasses belonging to the ternary system SiO(2)-CaO-Na(2)O. On the basis of previous results the glass composition was refined and the ion-exchange process was adapted to it, in order to tune the final material properties. The addition of Al(2)O(3) to the original glass system and the optimization of the ion-exchange conditions allowed a better control of the treatment, leading to an antibacterial material, without affecting both bioactivity and biocompatibility.

References

Biomaterials. 2003 May;24(10):1797-807 [PMID: 12593962]
J Biomed Mater Res. 2000 Sep 15;51(4):742-51 [PMID: 10880124]
J Biomed Mater Res. 1994 Jun;28(6):693-8 [PMID: 8071380]
Biomaterials. 2006 Apr;27(11):2331-9 [PMID: 16364434]
Biomaterials. 2000 Feb;21(4):393-8 [PMID: 10656321]
Circulation. 1999 Aug 3;100(5):553-8 [PMID: 10430771]
J Mater Sci Mater Med. 1998 Mar;9(3):129-34 [PMID: 15348901]
J Biomed Mater Res. 2000 Nov;52(2):360-4 [PMID: 10951376]
J Biomed Mater Res. 1998 Sep 15;41(4):511-8 [PMID: 9697022]
Clin Immunol. 2001 Oct;101(1):21-31 [PMID: 11580223]
Biomaterials. 2003 Dec;24(27):4921-8 [PMID: 14559005]
J Biomed Mater Res A. 2003 Aug 1;66(2):266-74 [PMID: 12888996]
Am J Kidney Dis. 2001 Nov;38(5):1082-8 [PMID: 11684563]
J Biomed Mater Res A. 2003 Sep 1;66(3):580-5 [PMID: 12918041]
J Mater Sci Mater Med. 2002 Aug;13(8):789-92 [PMID: 15348566]
Biomaterials. 2005 Sep;26(25):5111-9 [PMID: 15792537]
J Biomed Mater Res. 2000 Sep 5;51(3):484-90 [PMID: 10880092]
J Colloid Interface Sci. 2001 Jan 1;233(1):83-90 [PMID: 11112309]

MeSH Term

Anti-Bacterial Agents
Cell Line
Coated Materials, Biocompatible
Escherichia coli
Fibroblasts
Glass
Ion Exchange
Materials Testing
Microscopy, Electron, Scanning
Silver
Staphylococcus aureus
Surface Properties
X-Ray Diffraction

Chemicals

Anti-Bacterial Agents
Coated Materials, Biocompatible
Silver

Word Cloud

Similar Articles

Cited By